Abstract
The high plasma glucose induced in glucose metabolism disorders leads to the non‐enzymatic glucose‐dependent modification (glycation) of type 1 collagen, which is an essential component of bone tissue. The glycation of proteins induces the formation of advanced glycation end‐products, such as carboxymethyl arginine, which is preferentially generated in glycated collagen. However, the effect of advanced glycation end‐product formation on the characteristics of type 1 collagen remains unclear due to the lack of suitable in vitro experimental systems analyzing type 1 collagen. Here, we show that the glycation of type 1 collagen can be analyzed in vitro using a goldfish‐scale bone model. Our study using these scales provides evidence that the advanced glycation end‐product formation in type 1 collagen induced by glyoxal, the carboxymethyl arginine inducer, facilitates the crosslinking of type 1 collagen, decreasing both its strength and flexibility.
Keywords: Carboxymethyl arginine, Fish scales, Type 1 collagen
Here we show that the glycation of type 1 collagen can be analyzed in vitro using a goldfish‐scale bone model. Our study using these scales provides evidence that glycation of type I collagen alpha chains facilitates the crosslinking of type I collagen, decreasing both its strength and flexibility.

INTRODUCTION
Types 1 and 2 diabetes induce secondary pathologies, including bone disease1. In patients with type 1 diabetes, reduced bone mineral density and diabetic vascular complications have been reported to increase the risks of fracture and osteoporosis1. Conversely, patients with type 2 diabetes have comparable or even higher bone mineral density than healthy individuals2. Deranged bone turnover, as well as diabetic vascular complications, has been proposed to be related to an increased risk of fracture and osteoporosis3. However, the mechanism underlying diabetes‐induced fracture and osteoporosis has not been fully understood4.
Advanced glycation end‐products (AGEs) are compounds that are physiologically formed through the non‐enzymatic glucose‐dependent modification (glycation) of proteins5. In addition to glucose, carbonyl compounds, such as methylglyoxal, glycolaldehyde and glyoxal, generate various types of AGEs6. For example, methylglyoxal reacts with proteins to form carboxyethyl lysine7, whereas the reaction of glycolaldehyde with proteins generates glyceraldehyde‐derived pyridinium8. Furthermore, glyoxal induces the formation of carboxymethyl lysine and carboxymethyl arginine (CMA). Carboxymethyl lysine is one of the major antigenic AGE structures accumulating in various proteins9, whereas CMA is produced by oxidation in glycated collagen and, thus, is the AGE specific to collagen10.
The glycation of type 1 collagen is stimulated by a high plasma glucose concentration observed in patients with diabetes, and AGEs have been confirmed as a vital risk factor for developing diabetic complications11, 12. With respect to the quality of the bone, the possibility of altering bone matrix collagen properties through non‐enzymatic glycation was reported in type 2 diabetes patients13. In addition, a study reported that serum levels of pentosidine, an AGE product, and poor glycemic control were associated with prevalent fractures in type 1 diabetes patients independent of bone mineral density14. In line with these findings, elucidation of the effect of glyoxal, the inducer of collagen‐specific CMA, on the characteristics of type 1 collagen is expected to give insight into the mechanism underlying diabetes‐induced bone diseases.
Similar to mammalian bones, fish scales are composed of osteoblasts, osteoclasts and calcified bone matrixes, including type 1 collagen15, and they use a parathyroid hormone and calcitonin to regulate calcium metabolism in osteoblasts and osteoclasts, and help maintain blood calcium levels16, 17. In addition, fish scales are small and are present on the body surface, facilitating the extraction of bone components and the analysis of bone metabolism using low molecular compounds. The present study utilized fish scales to analyze the formation of AGEs in type 1 collagen and the effect of glyoxal on the characteristics of type 1 collagen in vitro.
MATERIALS AND METHODS
Evaluation of the effects of carbonyl compounds on type 1 collagen
Type 1 collagen was isolated from the regenerating scales of goldfish (Carassius auratus), as described previously18, and incubated with glyoxal (Wako Chemical Industries and Tokyo Chemical Industries, Tokyo, Japan), methylglyoxal (Sigma‐Aldrich, St. Louis, MO, USA) or glycolaldehyde (Sigma‐Aldrich) at 20°C. The samples were then fractionated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS‐PAGE) and stained with Coomassie Brilliant Blue or analyzed through western blotting (WB) as described below.
Western blotting
WB was carried out as described previously19. Proteins were detected using the following primary antibodies: mouse monoclonal CMA antibody (AGE‐M04, 1:500 dilution; Cosmo Bio Co., Ltd., Tokyo, Japan) and rabbit polyclonal goldfish type 1 collagen antibody (CL50171AP‐G, 1:1,000 dilution; Cedarlane Labs, Burlington, ON, Canada). Secondary fluorescent IRDye conjugated anti‐mouse and anti‐rabbit antibodies (1:10,000 dilution; LI‐COR Biosciences, Lincoln, NE, USA) were also used. Fluorescence images were acquired using an Odyssey Infrared Imager (LI‐COR Biosciences).
Determination of the mechanical properties of type 1 collagen
The mechanical properties of type 1 collagen were determined through a three‐point bending test using a mechanical tester (CR‐500DX‐SII; Sun Scientific, Tokyo, Japan; Figure 1). To prepare specimens, type 1 collagen was poured into a plastic molding die and lyophilized. A loading force was applied to the middle of the specimen, which had been placed on the supporting pins, using the loading actuator (Figure 1). The minimum loading force inducing specimen destruction, the force loading area, the height of the specimen before loading the force (original height: 2 mm) and the height of the specimen at the moment of destruction (height at destruction) were measured. These measured values were applied to equations 1 and 2, as presented in Figure 1, to calculate the bending stress (MPa) and deformation rate (%) of the specimen. Data were analyzed by using a one‐way anova, as compared with controls. Thereafter, we used the Dunnett's multiple comparison procedure for post‐hoc analysis. Significance was set at P < 0.05 with IBM SPSS Statistics software (IBM Corporation, Armonk, NY, USA).
Figure 1.

Schematic of the three‐point bending test. The type 1 collagen specimen was placed on the supporting pins. A loading force was applied to the middle of the specimen using the loading actuator. The minimum loading force inducing specimen destruction, the force loading area, the height of the specimen before loading the force (original height: 2 mm) and the height of the specimen at the moment of destruction (height at destruction) were measured. These measured values were applied to equations 1 and 2 to calculate the bending stress (MPa) and deformation rate (%) of the specimen.
RESULTS
To evaluate the effect of glyoxal on type 1 collagen in vitro, type 1 collagen was isolated from the scales of goldfish, incubated with glyoxal for 0, 24, 48 or 72 h, and analyzed by SDS‐PAGE. Type 1 collagen molecules comprise α1 and α2 chains; they were detected as bands corresponding to approximately 116 kDa (Figure 2a). The crosslinking in two or three of the α1/α2 chains resulted in the appearance of two types of low‐mobility bands: one corresponding to a β chain and the other to a γ chain (Figure 2b). Incubation for 24 h induced band shifts of the α, β and γ chains, and further increased the intensity of the γ chain signal (Figure 2b). Further incubation induced new lower‐mobility bands corresponding to δ chains, and decreased the signal intensities of the α and β chains in a time‐dependent manner (Figure 2b).
Figure 2.

Evaluation of the effect of glyoxal on the molecular mass of scale‐matrix type 1 collagen and the glyoxal‐induced carboxymethyl arginine (CMA) formation in type 1 collagen in vitro. (a) The isolated type 1 collagen was incubated with distilled water (lane a) or glyoxal (lane b) for the indicated times (0, 24, 48 and 72 h). Samples were then resolved by SDS‐PAGE and stained with Coomassie Brilliant Blue. α1, α2, β1, β2, γ and δ denote the α1, α2, β1, β2, γ and δ chain, respectively. As time passed after the addition of glyoxal (880 mmol/L) to the collagen solution, we found a band shift due to incremental changes in the molecular weight of the α and β fractions. (b) The relative intensities of the α1, β or γ chain bands in lane a and those of the α1, β or γ chain bands in lane b were densitometrically determined. Values obtained for the α1, β, γ or δ chain bands in lanes a (white bar) or b (grey bar) were normalized to those of the α1 chain bands in lane a for each given time point, and values at the time points resulting in peak signal levels were set to 100. The presented graph is from a single experiment and is representative of the three trials. (c) The type 1 collagens incubated with 880 mmol/L (lane a), 500 µmol/L (lane b) or 100 µmol/L (lane c) glyoxal or distilled water (lane d) for 72 h were analyzed by western blotting with type 1 collagen (upper panel) and CMA antibodies (lower panel). α, β, γ and δ denote the α, β, γ and δ chain, respectively.
Next, type 1 collagen was incubated with various concentrations of glyoxal for 72 h and analyzed by WB. Signals corresponding to the α, β and γ chains were detected in the type 1 collagen that was not incubated with glyoxal (Figure 2c, upper panel). Incubation with 500 µmol/L and 100 µmol/L glyoxal caused a significant shift in the mobility of the α, β and γ chains (lanes b and c). In addition, incubation with a higher concentration of glyoxal induced new lower‐mobility bands corresponding to the δ chains, and decreased the signal intensities of the α and β chains (lane a), consistent with the result in Figure 2a,b. Notably, the formation of CMA was detected in α, β, γ and δ chains in the type 1 collagens incubated with glyoxal (Figure 2c, lower panel).
The effects of glyceraldehyde and methylglyoxal on type 1 collagen were evaluated. Both were found to induce new lower‐mobility bands corresponding to the β, γ or δ chains in a concentration‐ or time‐dependent manner (Figure 3).
Figure 3.

Evaluation of the effects of carbonyl compounds on type 1 collagen in vitro. (a) The isolated type 1 collagen was incubated with 200 mmol/L (lane 1), 500 µmol/L (lane 2), 100 µmol/L (lane 3), or 25 µmol/L (lane 4) glyceraldehyde or distilled water (lane 5). Samples were then resolved by SDS‐PAGE and stained with Coomassie Brilliant Blue. (b) The isolated type 1 collagen was incubated with 500 mmol/L (lane 1), 500 µmol/L (lane 2), 100 µmol/L (lane 3) or 25 µmol/L (lane 4) methylglyoxal or distilled water (lane 5). Samples were then resolved by SDS‐PAGE and stained with Coomassie Brilliant Blue. (c) The isolated type 1 collagen was incubated with distilled water (Control), 500 µmol/L glyceraldehyde (GA) or 500 µmol/L methylglyoxal (MG) for the indicated times (0, 24, 48 and 72 h). Samples were then resolved by SDS‐PAGE and stained with Coomassie Brilliant Blue. α, β, γ and δ denote the α, β, γ and δ chain, respectively.
We carried out a three‐point bending test to determine the bending stress and deformation rate of type 1 collagen, which are indicators of its strength and flexibility, respectively. For this, type 1 collagen was isolated from goldfish scales and incubated with glyoxal for 0, 24, 48 or 72 h. As shown in Figure 4, incubation with glyoxal for ≥24 h significantly decreased the bending stress (strength) and deformation rate (flexibility) of type 1 collagen.
Figure 4.

Effects of non‐enzymatic modification of collagen by glycation on mechanical properties using a three‐point bending test. Type 1 collagen isolated from goldfish scales was incubated with glyoxal (880 mmol/L) for the indicated times. The (a) bending stress (strength) and (b) deformation rate (flexibility) were determined as described in the Methods section. Data were analyzed using a one‐way anova, as compared with controls. Thereafter, we used Dunnett's multiple comparison procedure for post‐hoc analysis. Significance was set at P < 0.05 with IBM SPSS Statistics software. Error bars in each graph represent the mean ± standard deviation of 10 independent experiments (*P < 0.05 and **P < 0.01).
DISCUSSION
Our previous study evaluated the bone metabolism for high‐glucose concentration in goldfish scales collected from fish with alloxan‐induced hyperglycemia20. The enzymatic activity and messenger ribonucleic acid expression of osteoblast and osteoclast markers were not significantly different between hyperglycemic and euglycemic goldfish scales. Accordingly, we proposed that hyperglycemia affects bone components other than bone cells, such as collagen and the bone matrix, leading to the deterioration of bone quality in a goldfish scale bone model. In support of this notion, the current study found that glyoxal‐induced AGE formation causes decreased flexibility and strength in type 1 collagen. It should be stressed that hyperglycemia‐induced glycation forms disorganized structures of collagen fibrils, which have a negative effect on the structural dynamics and stabilization of the diabetic bone matrix21, 22. In addition, it was reported that increased pentosidine in bone collagen was inversely correlated with the bone formation rate, bone volume ratio and mineral apposition rate in dialysis patients23. Taken together, it is conceivable that different AGEs have distinct effects on the characteristics of bone components and induce bone defects.
Our recent study using goldfish scales in outer space uncovered the molecular mechanism underlying microgravity‐induced osteoporosis‐like loss of bone mass in astronauts24, 25, 26. Furthermore, the current study established in vitro systems for analyzing the formation of AGEs in type 1 collagen and the effects of carbonyl compounds on the characteristics of collagen, thereby significantly increasing the value of fish scales for analyzing bone diseases and their association with other pathologies, such as hyperglycemic disease.
DISCLOSURE
The authors declare no conflict of interest.
Acknowledgments
This work was supported by the Japan Society for the Promotion of Science Grant‐in‐Aid for Scientific Research (24500848 [KK], 15K01705 [KK], 18K11016 [AH], 18KT0068 [JH], 20H04565 [JH], 20K06718 [NS] and 20K12619 [YT]).
J Diabetes Investig. 2021; 12: 1555–1559
References
- 1.Wu YY, Xiao E, Graves DT. Diabetes mellitus related bone metabolism and periodontal disease. Int J Oral Sci. 2015; 7(2): 63–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wongdee K, Charoenphandhu N. Update on type 2 diabetes‐related osteoporosis. World J Diabetes. 2015; 6(5): 673–678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Montagnani A, Gonnelli S, Alessandri M, et al. Osteoporosis and risk of fracture in patients with diabetes: an update. Aging Clin Exp Res. 2011; 23(2): 84–90. [DOI] [PubMed] [Google Scholar]
- 4.Ponti F, Guerri S, Sassi C, et al. Imaging of diabetic bone. Endocrine 2017; 58(3): 426–441. [DOI] [PubMed] [Google Scholar]
- 5.Sanches CP, Vianna AGD, Barreto FC. The impact of type 2 diabetes on bone metabolism. Diabetol Metab Syndr. 2017; 9: 85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Nagai R, Matsumoto K, Ling X, et al. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 2000; 49(10): 1714–1723. [DOI] [PubMed] [Google Scholar]
- 7.Nagai R, Fujiwara Y, Mera K, et al. Immunochemical detection of Nepsilon‐(carboxyethyl)lysine using a specific antibody. J Immunol Methods. 2008; 332(1–2): 112–120. [DOI] [PubMed] [Google Scholar]
- 8.Usui T, Shimohira K, Watanabe H, et al. Detection and determination of glyceraldehyde‐derived advanced glycation end product. BioFactors 2004; 21(1–4): 391–394. [DOI] [PubMed] [Google Scholar]
- 9.Glomb MA, Monnier VM. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem. 1995; 270(17): 10017–10026. [DOI] [PubMed] [Google Scholar]
- 10.Iijima K, Murata M, Takahara H, et al. Identification of N(omega)‐carboxymethylarginine as a novel acid‐labileadvanced glycation end product in collagen. Biochem J. 2000;347(Pt 1):23–27. [PMC free article] [PubMed] [Google Scholar]
- 11.Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N(epsilon)‐(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest. 1997; 99(3): 457–468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Compston J. Type 2 diabetes mellitus and bone. J Intern Med. 2018; 283(2): 140–153. [DOI] [PubMed] [Google Scholar]
- 13.Reiser KM. Nonenzymatic glycation of collagen in aging and diabetes. Proc Soc Exp Biol Med. 1991; 196(1): 17–29. [DOI] [PubMed] [Google Scholar]
- 14.Neumann T, Lodes S, Kästner B, et al. High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control. Osteoporos Int. 2014; 25(5): 1527–1533. [DOI] [PubMed] [Google Scholar]
- 15.Suzuki N, Somei M, Seki A, et al. Novel bromomelatonin derivatives as potentially effective drugs to treat bone diseases. J Pineal Res. 2008; 45(3): 229–234. [DOI] [PubMed] [Google Scholar]
- 16.Suzuki N, Danks JA, Maruyama Y, et al. Parathyroid hormone 1 (1–34) acts on the scales and involves calcium metabolism in goldfish. Bone 2011; 48(5): 1186–1193. [DOI] [PubMed] [Google Scholar]
- 17.Kase Y, Ikari T, Sekiguchi T, et al. Sardine procalcitonin amino‐terminal cleavage peptide has a different action from calcitonin and promotes osteoblastic activity in the scales of goldfish. Comp Biochem Physiol A Mol Integr Physiol. 2017; 211: 77–83. [DOI] [PubMed] [Google Scholar]
- 18.Pacak CA, Powers JM, Cowan DB. Ultrarapid purification of collagen type I for tissue engineering applications. Tissue Eng Part C Methods. 2011; 17(9): 879–885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Tabuchi Y, Hasegawa H, Suzuki N, et al. Low‐intensity pulsed ultrasound promotes the expression of immediate‐early genes in mouse ST2 bone marrow stromal cells. J Med Ultrason. 2020; 47(2): 193–201. [DOI] [PubMed] [Google Scholar]
- 20.Kitamura KI, Andoh T, Okesaku W, et al. Effects of hyperglycemia on bone metabolism and bone matrix in goldfish scales. Comp Biochem Physiol A Mol Integr Physiol. 2017; 203: 152–158. [DOI] [PubMed] [Google Scholar]
- 21.Yamauchi M, Katz EP, Otsubo K, et al. Cross‐linking and stereospecific structure of collagen in mineralized and nonmineralized skeletal tissues. Connect Tissue Res. 1989; 21(1–4): 159–167; discussion 68–9. [DOI] [PubMed] [Google Scholar]
- 22.Yamauchi M, Shiiba M. Lysine hydroxylation and cross‐linking of collagen. Methods Mol Biol. 2008; 446: 95–108. [DOI] [PubMed] [Google Scholar]
- 23.Mitome J, Yamamoto H, Saito M, et al. Nonenzymatic cross‐linking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients. Calcif Tissue Int. 2011; 88(6): 521–529. [DOI] [PubMed] [Google Scholar]
- 24.Ikegame M, Hattori A, Tabata MJ, et al. Melatonin is a potential drug for the prevention of bone loss during space flight. J Pineal Res. 2019; 67(3): e12594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Furusawa Y, Yamamoto T, Hattori A, et al. De novo transcriptome analysis and gene expression profiling of fish scales isolated from Carassius auratus during space flight: Impact of melatonin on gene expression in response to space radiation. Mol Med Rep. 2020; 22(4): 2627–2636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Yamamoto T, Ikegame M, Hirayama J, et al. Expression of sclerostin in the regenerating scales of goldfish and its increase under microgravity during space flight. Biomed Res. 2020; 41(6): 279–288. [DOI] [PubMed] [Google Scholar]
